MedTrace Logo

Short-term Function and Pain After Treatment for Dupuytren's Disease

NCT02301078 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-12-06

No results posted yet for this study

Summary

This study will evaluate short-term pain and function associated with percutaneous needle aponeurotomy (PNA) and injections of the enzyme collagenase clostridium histolyticum in patients with Dupuytren's disease. Scores on outcome measures will be compared between groups to determine whether treatments differ in terms of hand function and pain during the early post-treatment period.

Conditions

  • Dupuytren Disease

Interventions

PROCEDURE

Percutaneous Needle Aponeurotomy

single procedure (day 0)

DRUG

Collagenase clostridium histolyticum

Xiaflex injection into palpable cords (day 0), physical manipulation (day 7)

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-10-31
Completion
2017-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02301078 on ClinicalTrials.gov